APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brucella Melitensis Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Brucella Melitensis Vaccine Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchBrucella Melitensis Vaccine Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Brucella Melitensis Vaccine Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Brucella Melitensis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brucella Melitensis Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Brucella Melitensis Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Brucella Melitensis Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Brucella Melitensis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Brucella Melitensis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brucella Melitensis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Brucella Melitensis Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Brucella Melitensis Vaccine market include Jinyu, VETAL Animal Health Products Inc., Onderstepoort, MSD Animal Health, JOVAC, Hester Biosciences Limited, Dollvet, CZ Veterinaria and Antigen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Brucella Melitensis Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Brucella Melitensis Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Brucella Melitensis Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Brucella Melitensis Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Brucella Melitensis Vaccine Segment by Company

Jinyu

VETAL Animal Health Products Inc.

Onderstepoort

MSD Animal Health

JOVAC

Hester Biosciences Limited

Dollvet

CZ Veterinaria

Antigen

Brucella Melitensis Vaccine Segment by Type

Live Vaccines

Attenuated Vaccines

Brucella Melitensis Vaccine Segment by Application

Commercial Farming Enterprise

Private Farming

Brucella Melitensis Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Brucella Melitensis Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Brucella Melitensis Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Brucella Melitensis Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Brucella Melitensis Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucella Melitensis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brucella Melitensis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucella Melitensis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Brucella Melitensis Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Brucella Melitensis Vaccine industry.

Chapter 3: Detailed analysis of Brucella Melitensis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Brucella Melitensis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Brucella Melitensis Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Brucella Melitensis Vaccine Industry Trends Table 2. Brucella Melitensis Vaccine Industry Drivers Table 3. Brucella Melitensis Vaccine Industry Opportunities and Challenges Table 4. Brucella Melitensis Vaccine Industry Restraints Table 5. Global Brucella Melitensis Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Brucella Melitensis Vaccine Revenue Share by Company (2021-2026) Table 7. Global Brucella Melitensis Vaccine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Brucella Melitensis Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Brucella Melitensis Vaccine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Brucella Melitensis Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Brucella Melitensis Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Brucella Melitensis Vaccine Company, Product Type & Application Table 13. Global Brucella Melitensis Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Brucella Melitensis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Live Vaccines Table 18. Significant Companies of Attenuated Vaccines Table 19. Global Brucella Melitensis Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Brucella Melitensis Vaccine Sales Volume by Type (2021-2026) & (k units) Table 21. Global Brucella Melitensis Vaccine Sales Volume by Type (2027-2032) & (k units) Table 22. Global Brucella Melitensis Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Brucella Melitensis Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Brucella Melitensis Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Brucella Melitensis Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Brucella Melitensis Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Brucella Melitensis Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Brucella Melitensis Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Commercial Farming Enterprise Table 30. Significant Companies of Private Farming Table 31. Global Brucella Melitensis Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Brucella Melitensis Vaccine Sales Volume by Application (2021-2026) & (k units) Table 33. Global Brucella Melitensis Vaccine Sales Volume by Application (2027-2032) & (k units) Table 34. Global Brucella Melitensis Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global Brucella Melitensis Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global Brucella Melitensis Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Brucella Melitensis Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Brucella Melitensis Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Brucella Melitensis Vaccine Sales Value Share by Application (2021-2026) Table 40. Global Brucella Melitensis Vaccine Sales Value Share by Application (2027-2032) Table 41. Global Brucella Melitensis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Brucella Melitensis Vaccine Sales by Region (2021-2026) & (k units) Table 43. Global Brucella Melitensis Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Brucella Melitensis Vaccine Sales by Region (2027-2032) & (k units) Table 45. Global Brucella Melitensis Vaccine Sales Market Share by Region (2027-2032) Table 46. Global Brucella Melitensis Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Brucella Melitensis Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Brucella Melitensis Vaccine Sales Value Share by Region (2021-2026) Table 49. Global Brucella Melitensis Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Brucella Melitensis Vaccine Sales Value Share by Region (2027-2032) Table 51. Global Brucella Melitensis Vaccine Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Brucella Melitensis Vaccine Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Brucella Melitensis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Brucella Melitensis Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Brucella Melitensis Vaccine Sales by Country (2021-2026) & (k units) Table 56. Global Brucella Melitensis Vaccine Sales Market Share by Country (2021-2026) Table 57. Global Brucella Melitensis Vaccine Sales by Country (2027-2032) & (k units) Table 58. Global Brucella Melitensis Vaccine Sales Market Share by Country (2027-2032) Table 59. Global Brucella Melitensis Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Brucella Melitensis Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global Brucella Melitensis Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Brucella Melitensis Vaccine Sales Value Market Share by Country (2027-2032) Table 63. Jinyu Company Information Table 64. Jinyu Business Overview Table 65. Jinyu Brucella Melitensis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Jinyu Brucella Melitensis Vaccine Product Portfolio Table 67. Jinyu Recent Development Table 68. VETAL Animal Health Products Inc. Company Information Table 69. VETAL Animal Health Products Inc. Business Overview Table 70. VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Product Portfolio Table 72. VETAL Animal Health Products Inc. Recent Development Table 73. Onderstepoort Company Information Table 74. Onderstepoort Business Overview Table 75. Onderstepoort Brucella Melitensis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Onderstepoort Brucella Melitensis Vaccine Product Portfolio Table 77. Onderstepoort Recent Development Table 78. MSD Animal Health Company Information Table 79. MSD Animal Health Business Overview Table 80. MSD Animal Health Brucella Melitensis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. MSD Animal Health Brucella Melitensis Vaccine Product Portfolio Table 82. MSD Animal Health Recent Development Table 83. JOVAC Company Information Table 84. JOVAC Business Overview Table 85. JOVAC Brucella Melitensis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. JOVAC Brucella Melitensis Vaccine Product Portfolio Table 87. JOVAC Recent Development Table 88. Hester Biosciences Limited Company Information Table 89. Hester Biosciences Limited Business Overview Table 90. Hester Biosciences Limited Brucella Melitensis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Hester Biosciences Limited Brucella Melitensis Vaccine Product Portfolio Table 92. Hester Biosciences Limited Recent Development Table 93. Dollvet Company Information Table 94. Dollvet Business Overview Table 95. Dollvet Brucella Melitensis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Dollvet Brucella Melitensis Vaccine Product Portfolio Table 97. Dollvet Recent Development Table 98. CZ Veterinaria Company Information Table 99. CZ Veterinaria Business Overview Table 100. CZ Veterinaria Brucella Melitensis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. CZ Veterinaria Brucella Melitensis Vaccine Product Portfolio Table 102. CZ Veterinaria Recent Development Table 103. Antigen Company Information Table 104. Antigen Business Overview Table 105. Antigen Brucella Melitensis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Antigen Brucella Melitensis Vaccine Product Portfolio Table 107. Antigen Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Brucella Melitensis Vaccine Distributors List Table 111. Brucella Melitensis Vaccine Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Brucella Melitensis Vaccine Product Image Figure 2. Global Brucella Melitensis Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brucella Melitensis Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Brucella Melitensis Vaccine Sales (2021-2032) & (k units) Figure 5. Global Brucella Melitensis Vaccine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Brucella Melitensis Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Live Vaccines Image Figure 10. Attenuated Vaccines Image Figure 11. Global Brucella Melitensis Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Brucella Melitensis Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Brucella Melitensis Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Brucella Melitensis Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Brucella Melitensis Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Brucella Melitensis Vaccine Sales Value Share by Type (2021-2032) Figure 17. Commercial Farming Enterprise Image Figure 18. Private Farming Image Figure 19. Global Brucella Melitensis Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Brucella Melitensis Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Brucella Melitensis Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global Brucella Melitensis Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Brucella Melitensis Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Brucella Melitensis Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global Brucella Melitensis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Brucella Melitensis Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Brucella Melitensis Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Brucella Melitensis Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Brucella Melitensis Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Brucella Melitensis Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Brucella Melitensis Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Brucella Melitensis Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Brucella Melitensis Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Brucella Melitensis Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Brucella Melitensis Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Brucella Melitensis Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Brucella Melitensis Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Brucella Melitensis Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Brucella Melitensis Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Brucella Melitensis Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Attenuated Vaccines
Applications
  • Commercial Farming Enterprise
  • Private Farming
Companies covered
  • Jinyu
  • VETAL Animal Health Products Inc.
  • Onderstepoort
  • MSD Animal Health
  • JOVAC
  • Hester Biosciences Limited
  • Dollvet
  • CZ Veterinaria
  • Antigen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Brucella Melitensis Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Brucella Melitensis Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Brucella Melitensis Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Brucella Melitensis Vaccine Market Dynamics
  1. 2.1 Brucella Melitensis Vaccine Industry Trends
  2. 2.2 Brucella Melitensis Vaccine Industry Drivers
  3. 2.3 Brucella Melitensis Vaccine Industry Opportunities and Challenges
  4. 2.4 Brucella Melitensis Vaccine Industry Restraints
3 Brucella Melitensis Vaccine Market by Company
  1. 3.1 Global Brucella Melitensis Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Brucella Melitensis Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Brucella Melitensis Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Brucella Melitensis Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Brucella Melitensis Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Brucella Melitensis Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Brucella Melitensis Vaccine Company Product Type and Application
  8. 3.8 Global Brucella Melitensis Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Brucella Melitensis Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Brucella Melitensis Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Brucella Melitensis Vaccine Market by Type
  1. 4.1 Brucella Melitensis Vaccine Type Introduction
  2. 4.1.1 Live Vaccines
  3. 4.1.2 Attenuated Vaccines
  4. 4.2 Global Brucella Melitensis Vaccine Sales Volume by Type
  5. 4.2.1 Global Brucella Melitensis Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Brucella Melitensis Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Brucella Melitensis Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Brucella Melitensis Vaccine Sales Value by Type
  9. 4.3.1 Global Brucella Melitensis Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Brucella Melitensis Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Brucella Melitensis Vaccine Sales Value Share by Type (2021-2032)
5 Brucella Melitensis Vaccine Market by Application
  1. 5.1 Brucella Melitensis Vaccine Application Introduction
  2. 5.1.1 Commercial Farming Enterprise
  3. 5.1.2 Private Farming
  4. 5.2 Global Brucella Melitensis Vaccine Sales Volume by Application
  5. 5.2.1 Global Brucella Melitensis Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Brucella Melitensis Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Brucella Melitensis Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Brucella Melitensis Vaccine Sales Value by Application
  9. 5.3.1 Global Brucella Melitensis Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Brucella Melitensis Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Brucella Melitensis Vaccine Sales Value Share by Application (2021-2032)
6 Brucella Melitensis Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Brucella Melitensis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Brucella Melitensis Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Brucella Melitensis Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Brucella Melitensis Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Brucella Melitensis Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Brucella Melitensis Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Brucella Melitensis Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Brucella Melitensis Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Brucella Melitensis Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Brucella Melitensis Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Brucella Melitensis Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Brucella Melitensis Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Brucella Melitensis Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Brucella Melitensis Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Brucella Melitensis Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Brucella Melitensis Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Brucella Melitensis Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Brucella Melitensis Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Brucella Melitensis Vaccine Sales Value Share by Country, 2025 VS 2032
7 Brucella Melitensis Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Brucella Melitensis Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Brucella Melitensis Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Brucella Melitensis Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Brucella Melitensis Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Brucella Melitensis Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Brucella Melitensis Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Brucella Melitensis Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Brucella Melitensis Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Brucella Melitensis Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Brucella Melitensis Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Brucella Melitensis Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Jinyu
  2. 8.1.1 Jinyu Company Information
  3. 8.1.2 Jinyu Business Overview
  4. 8.1.3 Jinyu Brucella Melitensis Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Jinyu Brucella Melitensis Vaccine Product Portfolio
  6. 8.1.5 Jinyu Recent Developments
  7. 8.2 VETAL Animal Health Products Inc.
  8. 8.2.1 VETAL Animal Health Products Inc. Company Information
  9. 8.2.2 VETAL Animal Health Products Inc. Business Overview
  10. 8.2.3 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Product Portfolio
  12. 8.2.5 VETAL Animal Health Products Inc. Recent Developments
  13. 8.3 Onderstepoort
  14. 8.3.1 Onderstepoort Company Information
  15. 8.3.2 Onderstepoort Business Overview
  16. 8.3.3 Onderstepoort Brucella Melitensis Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Onderstepoort Brucella Melitensis Vaccine Product Portfolio
  18. 8.3.5 Onderstepoort Recent Developments
  19. 8.4 MSD Animal Health
  20. 8.4.1 MSD Animal Health Company Information
  21. 8.4.2 MSD Animal Health Business Overview
  22. 8.4.3 MSD Animal Health Brucella Melitensis Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 MSD Animal Health Brucella Melitensis Vaccine Product Portfolio
  24. 8.4.5 MSD Animal Health Recent Developments
  25. 8.5 JOVAC
  26. 8.5.1 JOVAC Company Information
  27. 8.5.2 JOVAC Business Overview
  28. 8.5.3 JOVAC Brucella Melitensis Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 JOVAC Brucella Melitensis Vaccine Product Portfolio
  30. 8.5.5 JOVAC Recent Developments
  31. 8.6 Hester Biosciences Limited
  32. 8.6.1 Hester Biosciences Limited Company Information
  33. 8.6.2 Hester Biosciences Limited Business Overview
  34. 8.6.3 Hester Biosciences Limited Brucella Melitensis Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hester Biosciences Limited Brucella Melitensis Vaccine Product Portfolio
  36. 8.6.5 Hester Biosciences Limited Recent Developments
  37. 8.7 Dollvet
  38. 8.7.1 Dollvet Company Information
  39. 8.7.2 Dollvet Business Overview
  40. 8.7.3 Dollvet Brucella Melitensis Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Dollvet Brucella Melitensis Vaccine Product Portfolio
  42. 8.7.5 Dollvet Recent Developments
  43. 8.8 CZ Veterinaria
  44. 8.8.1 CZ Veterinaria Company Information
  45. 8.8.2 CZ Veterinaria Business Overview
  46. 8.8.3 CZ Veterinaria Brucella Melitensis Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CZ Veterinaria Brucella Melitensis Vaccine Product Portfolio
  48. 8.8.5 CZ Veterinaria Recent Developments
  49. 8.9 Antigen
  50. 8.9.1 Antigen Company Information
  51. 8.9.2 Antigen Business Overview
  52. 8.9.3 Antigen Brucella Melitensis Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Antigen Brucella Melitensis Vaccine Product Portfolio
  54. 8.9.5 Antigen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Brucella Melitensis Vaccine Value Chain Analysis
  2. 9.1.1 Brucella Melitensis Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Brucella Melitensis Vaccine Sales Mode & Process
  6. 9.2 Brucella Melitensis Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Brucella Melitensis Vaccine Distributors
  9. 9.2.3 Brucella Melitensis Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst